Analyst Ratings for Ligand Pharma (LGND)

LGND Rating Summary

LGND Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LGND
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $226.25 (+59.2%) * Over Last 12-Mos
Rating Score: 6 / 10   Percentile Rank: 61%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/14/2021 Stephens Jacob Johnson New Coverage Overweight
(N/A)
200.00
(N/A)
147.00
(142.12)
-3.32% Details
10/6/2020 Barclays
» Updated 9/22/2021
Balaji Prasad New Coverage Overweight
(N/A)
180.00
(174.00)
97.15
(142.12)
46.29% Details
Like LGND Ratings? Also take a look at TVTX, PFNX, CBB, APPS

LGND Ratings News